347 related articles for article (PubMed ID: 28530684)
21. Relevance of studying T cell responses in SIV-infected rhesus macaques.
Valentine LE; Watkins DI
Trends Microbiol; 2008 Dec; 16(12):605-11. PubMed ID: 18964016
[TBL] [Abstract][Full Text] [Related]
22. [The immunological manifestations and cytological characteristics of infection caused by the simian immunodeficiency virus (SIV) in rhesus monkeys].
Persidskiĭ IuV; Shcherbinskaia AM; Barshteĭn IuA; Antonenko SV; Marichev IL
Tsitol Genet; 1993; 27(6):97-104. PubMed ID: 8066812
[TBL] [Abstract][Full Text] [Related]
23. The value of primate models for studying human immunodeficiency virus pathogenesis.
Levy JA
J Med Primatol; 1996 Jun; 25(3):163-74. PubMed ID: 8892037
[TBL] [Abstract][Full Text] [Related]
24. Two-Year Follow-Up of Macaques Developing Intermittent Control of the Human Immunodeficiency Virus Homolog Simian Immunodeficiency Virus SIVmac251 in the Chronic Phase of Infection.
Shytaj IL; Nickel G; Arts E; Farrell N; Biffoni M; Pal R; Chung HK; LaBranche C; Montefiori D; Vargas-Inchaustegui D; Robert-Guroff M; Lewis MG; Sacha JB; Palamara AT; Savarino A
J Virol; 2015 Aug; 89(15):7521-35. PubMed ID: 25972547
[TBL] [Abstract][Full Text] [Related]
25. SHIV-1157i and passaged progeny viruses encoding R5 HIV-1 clade C env cause AIDS in rhesus monkeys.
Humbert M; Rasmussen RA; Song R; Ong H; Sharma P; Chenine AL; Kramer VG; Siddappa NB; Xu W; Else JG; Novembre FJ; Strobert E; O'Neil SP; Ruprecht RM
Retrovirology; 2008 Oct; 5():94. PubMed ID: 18928523
[TBL] [Abstract][Full Text] [Related]
26. Antibodies and resistance to natural HIV infection.
Nabel GJ; Sullivan NJ
N Engl J Med; 2000 Oct; 343(17):1263-5. PubMed ID: 11071680
[No Abstract] [Full Text] [Related]
27. Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaques.
Van Rompay KK; Marthas ML; Lifson JD; Berardi CJ; Vasquez GM; Agatep E; Dehqanzada ZA; Cundy KC; Bischofberger N; Pedersen NC
AIDS Res Hum Retroviruses; 1998 Jun; 14(9):761-73. PubMed ID: 9643376
[TBL] [Abstract][Full Text] [Related]
28. Candidate vaccines protect macaques against primate immunodeficiency viruses.
Stott J; Hu SL; Almond N
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S265-70. PubMed ID: 9814954
[TBL] [Abstract][Full Text] [Related]
29. Progress and challenges in therapies for AIDS in nonhuman primate models.
Haigwood NL
J Med Primatol; 1999; 28(4-5):154-63. PubMed ID: 10593480
[TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of simian, simian-human, and human immunodeficiency virus infections in the pigtail macaque (Macaca nemestrina) model.
Batten CJ; De Rose R; Wilson KM; Agy MB; Chea S; Stratov I; Montefiori DC; Kent SJ
AIDS Res Hum Retroviruses; 2006 Jun; 22(6):580-8. PubMed ID: 16796533
[TBL] [Abstract][Full Text] [Related]
31. [Contribution of animal models to HIV research].
Huot N; Rascle P; Müller-Trutwin M
Virologie (Montrouge); 2019 Aug; 23(4):229-240. PubMed ID: 31414660
[TBL] [Abstract][Full Text] [Related]
32. The chimpanzee and other non-human-primate models in HIV-1 vaccine research.
Nath BM; Schumann KE; Boyer JD
Trends Microbiol; 2000 Sep; 8(9):426-31. PubMed ID: 10989311
[TBL] [Abstract][Full Text] [Related]
33. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
[TBL] [Abstract][Full Text] [Related]
34. Animal models for HIV infection and AIDS: memorandum from a WHO meeting.
Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118
[TBL] [Abstract][Full Text] [Related]
35. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
[TBL] [Abstract][Full Text] [Related]
36. Repetitive exposures with simian/human immunodeficiency viruses: strategy to study HIV pre-clinical interventions in non-human primates.
Kim CN; Adams DR; Bashirian S; Butera S; Folks TM; Otten RA
J Med Primatol; 2006 Aug; 35(4-5):210-6. PubMed ID: 16872284
[TBL] [Abstract][Full Text] [Related]
37. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
38. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies.
Ferrantelli F; Rasmussen RA; Buckley KA; Li PL; Wang T; Montefiori DC; Katinger H; Stiegler G; Anderson DC; McClure HM; Ruprecht RM
J Infect Dis; 2004 Jun; 189(12):2167-73. PubMed ID: 15181562
[TBL] [Abstract][Full Text] [Related]
39. Accelerating HIV vaccine development using non-human primate models.
Rahman MA; Robert-Guroff M
Expert Rev Vaccines; 2019 Jan; 18(1):61-73. PubMed ID: 30526159
[TBL] [Abstract][Full Text] [Related]
40. Antiretroviral Drug Activity in Macaques Infected during Pre-Exposure Prophylaxis Has a Transient Effect on Cell-Associated SHIV DNA Reservoirs.
Cong ME; Pau CP; Heneine W; García-Lerma JG
PLoS One; 2016; 11(11):e0164821. PubMed ID: 27806064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
